Three samples from the periphery of this tumour (all classified as Ductal Carcinoma in situ) were obtained from the surgical formalin-fixed block; all carried the founder clone BIRC6 and PIK3CA mutations, and one carried the BRAF mutation found in cluster 3. Here, BRAF is linked to ductal breast carcinoma in situ.